Stephen Schwartz, known for his work on the vascular system, is the first person associated with the university to succumb to infection with SARS-CoV-2.

The World Health Organization warns that a lack of data on how many people have the disease could undermine containment and mitigation efforts in many countries.

Manufacturing sites are ramping up production of reagents needed to isolate SARS-CoV-2’s genetic material—a key step in testing for the virus.

The creativity of citizen scientists could help researchers design proteins that may be able to fight the SARS-CoV-2 virus.

Our maps and charts, updated regularly, offer a striking view of the global move of the novel coronavirus.

China and Japan have also closed their schools, prompting universities worldwide to assess the threat this virus poses to their local and international communities.

More cases emerge across the country as the global death toll from COVID-19 surpasses 3,000.

An increase in confirmed infections, particularly in Italy, Iran, and South Korea, has led to heightened measures to prevent the spread of the virus SARS-CoV-2.

Emerging data as well as knowledge from the SARS and MERS coronavirus outbreaks yield some clues as to why SARS-CoV-2 affects some people worse than others.